Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0010453,
umls-concept:C0025663,
umls-concept:C0028778,
umls-concept:C0037993,
umls-concept:C0205265,
umls-concept:C0205369,
umls-concept:C0301896,
umls-concept:C0439662,
umls-concept:C0871261,
umls-concept:C1521761,
umls-concept:C1533691,
umls-concept:C1555582,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1880022,
umls-concept:C2911692
|
pubmed:issue |
5
|
pubmed:dateCreated |
1975-9-29
|
pubmed:abstractText |
Spleen cells from BALB/c mice which either bore syngeneic sarcomas or were normal controls were cultured in vitro. The culture supernatants of spleen cells from tumor-bearing mice inhibited (blocked) specific cell-mediated cytotoxicity to the tumor borne by the spleen donor. They also mediated specific antiserum-dependent cytotoxicity with control lymphoid cells. The appearance of blocking activity in culture supernatants was prevented by lysis of theta-positive spleen cells with antiserum and complement. The blocking activity was removed by passing culture supernatants through an anti-mouse immunoglobulin affinity column and was recovered in a 3 M NaSCN eluate of the column.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
806-14
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:1140873-Animals,
pubmed-meshheading:1140873-Cell Line,
pubmed-meshheading:1140873-Complement System Proteins,
pubmed-meshheading:1140873-Cytotoxicity Tests, Immunologic,
pubmed-meshheading:1140873-Immune Sera,
pubmed-meshheading:1140873-Immunoglobulins,
pubmed-meshheading:1140873-Mice,
pubmed-meshheading:1140873-Sarcoma, Experimental,
pubmed-meshheading:1140873-Spleen
|
pubmed:year |
1975
|
pubmed:articleTitle |
Specific anti-tumor responses by cultured immune spleen cells. I. In vitro culture method and initial characterization of factors which block immune cell-mediated cytotoxicity in vitro.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|